Found: 15
Select item for more details and to access through your institution.
Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4.
- Published in:
- European Journal of Immunology, 2010, v. 40, n. 10, p. 2942, doi. 10.1002/eji.201040516
- By:
- Publication type:
- Article
Personal digital assistant-based drug information sources: potential to improve medication safety.
- Published in:
- Journal of the Medical Library Association, 2005, v. 93, n. 2, p. 229
- By:
- Publication type:
- Article
Diffusion tensor imaging the medial longitudinal fasciculus in INO: opportunities and challenges.
- Published in:
- Annals of the New York Academy of Sciences, 2011, v. 1233, n. 1, p. 307, doi. 10.1111/j.1749-6632.2011.06156.x
- By:
- Publication type:
- Article
Rituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic success.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 7, p. 1022, doi. 10.1177/1352458511432896
- By:
- Publication type:
- Article
Multiple sclerosis-related white matter microstructural change alters the BOLD hemodynamic response.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2016, v. 36, n. 11, p. 1872, doi. 10.1177/0271678X15615133
- By:
- Publication type:
- Article
The Effect of Glatiramer Acetate Therapy on Functional Properties of B Cells From Patients With Relapsing-Remitting Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2014, v. 71, n. 11, p. 1421, doi. 10.1001/jamaneurol.2014.1472
- By:
- Publication type:
- Article
JC Virus in CD34<sup>+</sup> and CD19<sup>+</sup> Cells in Patients With Multiple Sclerosis Treated With Natalizumab.
- Published in:
- JAMA Neurology, 2014, v. 71, n. 5, p. 596, doi. 10.1001/jamaneurol.2014.63
- By:
- Publication type:
- Article
Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis.
- Published in:
- Annals of Neurology, 2010, v. 67, n. 6, p. 749, doi. 10.1002/ana.22005
- By:
- Publication type:
- Article
Changes in JC Virus-Specific T Cell Responses during Natalizumab Treatment and in Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.
- Published in:
- PLoS Pathogens, 2012, v. 8, n. 11, p. 1, doi. 10.1371/journal.ppat.1003014
- By:
- Publication type:
- Article
Correlating Function and Imaging Measures of the Medial Longitudinal Fasciculus.
- Published in:
- PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0147863
- By:
- Publication type:
- Article
Nurses' Perspective on Approaches to Limit Flu-Like Symptoms During Interferon Therapy for Multiple Sclerosis.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Facilitating Medication Adherence in Patients with Multiple Sclerosis.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Symptomatic therapy in multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2011, v. 4, n. 2, p. 83, doi. 10.1177/1756285611400658
- By:
- Publication type:
- Article
A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing—remitting multiple sclerosis (TIME MS).
- Published in:
- Therapeutic Advances in Neurological Disorders, 2010, v. 3, n. 1, p. 3, doi. 10.1177/1756285609355851
- By:
- Publication type:
- Article
A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2010, v. 3, n. 1, p. 15, doi. 10.1177/1756285609353354
- By:
- Publication type:
- Article